From Name:
From Email:
To Name:
To Email:

Optional Message:

Ohio drug startup focused on MRSA infection

from MedCity News

An Ohio University startup is developing a new antibacterial drug that would keep so-called "superbugs" such as MRSA from replicating in the body. Promiliad Biopharma is hoping its early development efforts yield a new drug capable of beating bacteria that have grown resistant to most antibiotics on the market. The most well-known example is a Methicillin-resistant Staphylococcus Aureus, or MRSA, infection. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063